Research ArticleResearch

Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence

Retrospective cohort study of 30 patients

Joe Dooley, Lianne Gerber-Finn, Irwin Antone, John Guilfoyle, Brittany Blakelock, Jazmyn Balfour-Boehm, Wilma M. Hopman, Naana Jumah and Len Kelly
Canadian Family Physician April 2016; 62 (4) e194-e200;
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Respond to this article
Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence
Joe Dooley, Lianne Gerber-Finn, Irwin Antone, John Guilfoyle, Brittany Blakelock, Jazmyn Balfour-Boehm, Wilma M. Hopman, Naana Jumah, Len Kelly
Canadian Family Physician Apr 2016, 62 (4) e194-e200;
Twitter logo Facebook logo Mendeley logo

Jump to section

Subjects